Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A, Isoform 1-TAT
RP01167
Product Specifications
| Product Type | Recombinant protein |
|---|---|
| Applications | Bioactivity, Endotoxin |
| Source | E. coli. |
| UniProt No. | P42771 |
| Purity | > 95 % by SDS-PAGE and HPLC analyses. |
| Bioactivity | Data is not available. |
| Endotoxin | Less than 1 EU/μg of rHuP16-INK4a-TAT as determined by LAL method. |
| Molecular Weight | Approximately18.0 kDa, a single non-glycosylated polypeptide chain containing 167 amino acids. |
| Formulation | Lyophilized from a 0.2 μm filtered concentrated solution in 2 × PBS, pH 7.0. |
| Alternative Names | CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16, Human |
| Storage | -20C |
| Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
| Research Area | Others |